Kansas City, MO, United States of America

Faraneh Attarchi



Average Co-Inventor Count = 8.0

ph-index = 4

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 1998-2012

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Profile: Faraneh Attarchi

Introduction

Faraneh Attarchi, an innovative inventor based in Kansas City, MO, has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Attarchi has focused on developing novel pharmaceutical compositions that can enhance therapeutic outcomes.

Latest Patents

Among his latest innovations is a pharmaceutical composition for piperidinoalkanol compounds. This invention provides a solid unit dosage form, consisting of:

a) a therapeutically effective amount of a piperidinoalkanol compound or a pharmaceutically acceptable salt thereof; and

b) at least one inert ingredient.

This composition aims to improve the delivery and effectiveness of medications derived from piperidinoalkanol compounds.

Career Highlights

Faraneh Attarchi's professional journey includes significant roles at prominent companies such as Hoechst Marion Roussel and Aventis Pharmaceuticals Inc. His experience in these organizations has helped him hone his skills and drive innovation in the pharmaceutical industry.

Collaborations

Attarchi has been fortunate to collaborate with talented professionals throughout his career, including notable colleagues Thomas T Ortyl and Paul F Skultety. These collaborations have fostered a creative environment conducive to advancing their shared goals in pharmaceutical innovation.

Conclusion

Faraneh Attarchi is a noteworthy figure in the realm of pharmaceutical inventions, with a strong focus on enhancing therapeutic formulations. His contributions continue to influence the industry, showcasing the importance of innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…